Why stringent safety requirements, contamination threats and the rising risk of market terrorists are driving demand in product recall insurance.
Insurance for the medicines and biotech sector is growing increasingly complex and dynamic, and brokers need to consider every conceivable risk — to companies, consumers and even lab animals.
When management liability really comes into its own.
A flexible approach to work and study is a winning strategy for broker Gemma Gould.
Key figures from motor fleet insurance share their views on the big issues currently affecting the sector
Australia’s largest insurance broker cluster group, Steadfast, is proposing a public float. What will it mean to the shareholder
members of the currently unlisted private company? We speak to Chairman and CEO Robert Kelly.
Designed by eroomcreative | Engineered for success by EmpireOne
Follow us on: